| Literature DB >> 19860881 |
Francesca Comitini1, Ilaria Mannazzu, Maurizio Ciani.
Abstract
BACKGROUND: Killer yeasts have been used to combat contaminating wild yeasts in food, to control pathogenic fungi in plants, and in the medical field, to develop novel antimycotics for the treatment of human and animal fungal infections. Among these killer yeasts, Tetrapisispora phaffii (formerly known as Kluyveromyces phaffii) secretes a glycoprotein known as Kpkt that is lethal to spoilage yeasts under winemaking conditions. In the present study, the mode of action of Kpkt, and the specific damage produced by this toxin on sensitive yeasts is investigated.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19860881 PMCID: PMC2779178 DOI: 10.1186/1475-2859-8-55
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Effects of the β-glucanase inhibitor castanospermine on Kpkt killer activity.
| Purified Kpkt | Enzymatic activity | Killer activity | Viable cell counts |
|---|---|---|---|
| No castanospermine | 0.032 | 11.0 | 0.5 × 102 |
| 25 μM castanospermine | 0.0001 | 0.0 | 1.5 × 105 |
The Kpkt treatment was carried out with 25 μg toxin for 24 h at 25°C. The initial inoculum of the sensitive strain was 105 cell ml-1. Growth of the sensitive cells was measured through viable plate counts.
Figure 1Flow cytometry analysis of the sensitive strain. 106 cells ml-1 treated with 25 μg Kpkt for 24 h at 20°C, showing propidium iodide stained DBVPG 6500: (a) spheroplasts with heat-inactivated Kpkt; (b) spheroplast with Kpkt; and (c) sensitive whole cells with Kpkt. The peak on the left on the x axis is made up of viable spheroplasts/cell (not permeable to propidium iodide). The peak on the right of the x axis is made up of dead spheroplasts/cells (permeable to propidium iodide). Percentages represent the mortality after flow-cytometry analyses.
Effect of Kpkt on spheroplasts
| Trial | % dead cellsa |
|---|---|
| Spheroplasts + heat treated Kpkt | 0.29 ± 0.23 |
| Spheroplasts + Kpkt | 1.39 ± 0.42 |
| Whole cells + Kpkt | 98.5 ± 0.77 |
The initial inoculum (106 cell ml-1) was considered as 100%. Data are means ± SD of three experiments.
Kpkt activity in the presence and absence of sorbitol as an osmotic stabilizer
| Medium | % Dead cellsa | |
|---|---|---|
| Thoma-Zeiss counting chamber | Viable cell counts After 48 h | |
| Whole sensitive cells + Kpkt | 5.4 ± 1.0 | 4.0 ± 0.8 |
| Whole sensitive cells + Kpkt | 55.4 ± 5.2 | 93.9 ± 3.0 |
a The initial inoculum (106 cell ml-1) was considered as 100%. Data are means ± SD of three experiments.
Figure 2Calcofluor White. (a) untreated cells; (b) cells heat treated at 100°C for 10 min; (c) cells treated with 70% ethanol for 3 h; (d) cells broken after treatment for 2 h at 37°C with 0.02 UI of zymolyase; (e) cells treated for 24 h with 50 μg purified Kpkt; and (f) cells treated for 24 h with partially purified K1.
Figure 3Scanning electron microscopy analysis of the . (a) Untreated cells; (b) cells treated for 24 h with 46 aU Kpkt; and (c) cells treated for 24 h with 46 aU K1.
Figure 4Scanning of the surface (6.25 μm. (a) Untreated cells; (b) cells treated for 24 h with 100 μg ml-1 purified Kpkt; and (c) cells treated for 24 h with 46 aU K1.
Effects of increasing concentrations of laminarinase on Kpkt sensitive and resistant strains: comparison with Kpkt.
| Sample | Concentration (mg ml-1) | % dead cells | |
|---|---|---|---|
| Kpkt | 0.05 | 65.4 | 5.4 |
| Laminarinase | 0.05 | 1.3 | 3.5 |
| 2.5 | 15.2 | 17.2 | |
| 12.5 | 40.8 | 52.7 | |
| 25 | 63.7 | 78.4 | |
Percentages of dead cells was evaluated by flow cytometry after propidium iodide staining.
Effects of endoglycosidase-H treatment on Kpkt killer activity.
| Conditions | After 24 h incubation | After 48 h incubation |
|---|---|---|
| Without Kpkt | 17.0 ± 1.27 | 56.0 ± 8.48 |
| With Kpkt | 0.5 ± 0.14 | 0.03 ± 0.016 |
| With Kpkt + Endo H | 6.4 ± 0.42 | 6.7 ± 0.56 |
| With Kpkt and without Endo H | 0.29 ± 0.098 | 0.43 ± 0.013 |
The initial inoculum of sensitive cells was 2 × 105 cell ml-1. Data are means ± SD of three experiments.